Citation Impact
Citing Papers
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Reconstituting Organ-Level Lung Functions on a Chip
2010 StandoutScience
Acute kidney injury in decompensated cirrhosis
2012
NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis
2018
Redox mechanisms in hepatic chronic wound healing and fibrogenesis
2008
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
2013
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
2012
Polycyclic aromatic hydrocarbon‐DNA adducts in liver tissues of hepatocellular carcinoma patients and controls
2002
CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells
1999
Primary Biliary Cirrhosis
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients
2001
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome
2007
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Surgical shunts and tips for variceal decompression in the 1990s
2000
Management of adult patients with ascites due to cirrhosis†
2004
Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension
2007
Prophylactic Use of Transjugular Intrahepatic Portosystemic Shunt Aids in the Treatment of Refractory Ascites
2013
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
1993 Standout
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
2015
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis
2016
Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
2007
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
2010
Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience
2016
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
2012
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis
2017
Structure and function of glutathione S-transferases
1994
Review article: the burden of hepatic encephalopathy
2007
Midodrine and Clonidine in Patients With Cirrhosis and Refractory or Recurrent Ascites: A Randomized Pilot Study
2013
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis
2003
Hyponatremia in cirrhosis: From pathogenesis to treatment†
1998
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt
2006
Renal Effects of Ibuprofen, Piroxicam, and Sulindac in Patients with Asymptomatic Renal Failure
1990
Renal Failure in Cirrhosis
2009
Drug-Induced Hepatotoxicity
2003 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
2015
Value of the Hepatic Venous Pressure Gradient to Monitor Drug Therapy for Portal Hypertension: A Meta-Analysis
2007
Cost‐effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances
2007
Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study
2015
Acute-on-chronic liver failure in cirrhosis
2016
Surveillance for Hepatocellular Carcinoma Improves Survival in Asian-American Patients with Hepatitis B: Results from a Community-Based Clinic
2009
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis
2005
Clinical Course of Alcoholic Liver Cirrhosis: A Danish Population-Based Cohort Study
2009
TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: An updated meta-analysis
2014
Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia.
1989
Expanding consensus in portal hypertension
2015 Standout
Vascular disorders of the liver # †
2008 Standout
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial
2008
Portal hypertension in primary biliary cirrhosis
1987
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
1996
The Use of E/A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt
2009
The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation
2010
Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data
2007
Portal hypertension and variceal bleeding—Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
2008
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
The Serum-Ascites Albumin Gradient Is Superior to the Exudate-Transudate Concept in the Differential Diagnosis of Ascites
1992
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
2002
Terlipressin for hepatorenal syndrome
2012
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
2006
Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure
2016
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation
2000
Mechanisms of endotoxin-induced NO, IL-6, and TNF-α production in activated rat hepatic stellate cells: Role of p38 MAPK
2006
Management and outcome in hepatorenal syndrome: need for renal replacement therapy in non-transplanted patients
2013
Liver transplantation in patients with hepatic hydrothorax
2005
X-inactivation profile reveals extensive variability in X-linked gene expression in females
2005 StandoutNature
Characterization of a Stellate Cell Activation-associated Protein (STAP) with Peroxidase Activity Found in Rat Hepatic Stellate Cells
2001
A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites
2005
Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis
2015
Management of Varices and Variceal Hemorrhage in Cirrhosis
2010
Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis
2016
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding
2004
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites†
2005
Management of adult patients with ascites caused by cirrhosis†
1998
Alcoholic Liver Disease
1989
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications
2013
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Metabolism and functions of glutathione in brain
2000 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Acute kidney injury in cirrhosis
2008
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
2015
Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients
2008
Association of AKI With Mortality and Complications in Hospitalized Patients With Cirrhosis
2012
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Drug metabolism and hepatotoxicity.
1991
Kidney biomarkers in cirrhosis
2016
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice
2012
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
1999
Mesenteric Venous Thrombosis
2013
Revealing the world of RNA interference
2004 StandoutNatureNobel
Hepatic Hydrothorax
2014
Enhanced expression of glutathione-S-transferase A1-1 protects against oxidative stress in human retinal pigment epithelial cells
2004
Distributed hepatocytes expressing telomerase repopulate the liver in homeostasis and injury
2018 Nature
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Measurement of Spleen Stiffness by Acoustic Radiation Force Impulse Imaging Identifies Cirrhotic Patients With Esophageal Varices
2012
An Open Label, Pilot, Randomized Controlled Trial of NoradrenalineVersusTerlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response
2008
Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence
1991
Role of Transjugular Intrahepatic Portosystemic Shunts in the Management of Hepatopulmonary Syndrome: A Systemic Literature Review
2015
Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis
2015
Predictors of Response to Therapy With Terlipressin and Albumin in Patients With Cirrhosis and Type 1 Hepatorenal Syndrome
2009
Paracetamol (acetaminophen) poisoning
1993
Clinical states of cirrhosis and competing risks
2017
Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A systematic review
2011
Pegylation
2001
Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
2014
Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial
2010
Liver Biopsy
2001 Standout
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections
2017
Identification and Characterization of a Novel Microsomal Enzyme with Glutathione-dependent Transferase and Peroxidase Activities
1997
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Aldehydes potentiate α2(I) collagen gene activity by JNK in hepatic stellate cells
2001
Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal Hypertension in Cirrhosis
2008
Universal Occurrence of Glomerular Abnormalities in Patients Receiving Liver Transplants
1992
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis
2012
The hepatic venous pressure gradient: Anything worth doing should be done right
2004
Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis
2017
Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites
1994
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?
2015
Hepatocellular Carcinoma
2019 Standout
MAMMALS THAT BREAK THE RULES: Genetics of Marsupials and Monotremes
1996
Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion
1983
The Molecular Action and Regulation of the Testis-Determining Factors, SRY (Sex-Determining Region on the Y Chromosome) and SOX9 [SRY-Related High-Mobility Group (HMG) Box 9]
2003
Drug-induced vasculitides
1991
Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: Evidence for increased vasoconstrictor and decreased vasodilator factors
1983
Portal Pressure, Presence of Gastroesophageal Varices and Variceal Bleeding
1985
Primary Biliary Cirrhosis
1987 Standout
Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites: An overview with emphasis on pathogenesis
1986
Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes
2015
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study
2015
Primary Biliary Cirrhosis
2011 Standout
The allopurinol hypersensitivity syndrome
1979
Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo Applications
2007 StandoutNobel
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
2007
Chronic Excessive Acetaminophen Use and Liver Damage
1977
Terlipressin in Hepatorenal Syndrome
2011
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Functional Coherence of the Human Y Chromosome
1997 StandoutScience
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections
2017
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
2003
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Why and how to measure renal function in patients with liver disease
2017
Derangements of renal water handling in liver disease
1985
Interference of hepatitis C virus RNA replication by short interfering RNAs
2003
PREDICTIVE VALUE OF IN VITRO MODEL SYSTEMS IN TOXICOLOGY
1998
The role of propranolol in congestive gastropathy of portal hypertension
1987
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Portal Hypertension and Its Complications
2008
Variations of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Balloon-occluded Antegrade Transvenous Obliteration (BATO) and Alternative/Adjunctive Routes for BRTO
2011
SYMPATHETIC TONE MODULATES PORTAL VENOUS PRESSURE IN ALCOHOLIC CIRRHOSIS
1986
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients
1991
Sympathetic Nervous Activity and Renal and Systemic Hemodynamics in Cirrhosis: Plasma Norepinephrine Concentration, Hepatic Extraction, and Renal Release
1982
Altered renal and platelet arachidonic acid metabolism in cirrhosis
1986
Renal Kallikrein Excretion in Cirrhotics with Ascites: Relationship to Renal Hemodynamics†
1984
Cardiac volume overload and pulmonary hypertension in long‐term follow‐up of patients with a transjugular intrahepatic portosystemic shunt
2016
Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis
1984
Infections complicating cirrhosis
2018
Hepatic glutathione and glutathione S-conjugate transport mechanisms.
1998
Metal–Organic Frameworks in Biomedicine
2011 Standout
Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis
1980
Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension
2015
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
1984 Standout
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
2004 Standout
Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome
1984
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study
2016
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites
1987
Renal prostaglandins and the control of renal function in liver disease
1986
Complexity and contradiction in clinical trial research
1987
Chemical Implications for Antitumor and Antiviral Prostaglandins: Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols
1997 StandoutNobel
Works of Thomas Boyer being referenced
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
2015
Changing clinical practice with measurements of portal pressure
2004
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease
1997
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
2010
American Association for the Study of Liver Diseases Practice Guidelines: The Role of Transjugular Intrahepatic Portosystemic Shunt Creation in the Management of Portal Hypertension
2005
Conversion of Failed Transjugular Intrahepatic Portosystemic Shunt to Distal Splenorenal Shunt in Patients With Child A or B Cirrhosis
1998
Differentiation-Induced Enhancement of the Ability of Cultured Human Keratinocytes to Suppress Oxidative Stress
1995
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting
2000
Human Glutathione S-Transferases
1998
Tolvaptan and Hyponatremia in A Patient With Cirrhosis
2010
Activation of rat hepatic stellate cells leads to loss of glutathion S -transferases and their enzymatic activity against products of oxidative stress
1999
Screening in liver disease: Report of an AASLD clinical workshop
2004
Effect of distal splenorenal shunt on survival of patients with primary biliary cirrhosis
1994
Transjugular intrahepatic portosystemic shunt: current status1 1Abbreviation used in this paper: TIPS, transjugular intrahepatic portosystemic shunt.
2003
Predictors of Large Esophageal Varices in Patients With Cirrhosis
1999
Pharmacologic treatment of portal hypertension: Past, present, and future
2001
Hepatic Hydrothorax
1997
Constitutional telomerase mutations are genetic risk factors for cirrhosis
2011
Special article the glutathione S-transferases: An update
1989
Alcohol Consumption by Cirrhotic Subjects: Patterns of Use and Effects on Liver Function
2008
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites
2015
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension†
2005
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Distal Splenorenal Shunt Versus Transjugular Intrahepatic Portal Systematic Shunt for Variceal Bleeding: A Randomized Trial
2006
A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome
2008
Transjugular Intrahepatic Portosystemic Shunt for the Management of Severe Venoocclusive Disease Following Bone Marrow Transplantation
1996
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1
2011
Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.
1979
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
2014
Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease
1979
Portal and systemic bacteraemia and endotoxaemia in liver disease.
1978
Localization of a portion of the active site of two rat liver glutathione S-transferases using a photoaffinity label
1989
Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy
1980
Acetaminophen-Induced Hepatic Necrosis and Renal Failure
1971
Use of diuretics in the treatment of cirrhotic ascites
1983
Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C
2001
Diagnostic Value of Ascitic Fluid Lactic Dehydrogenase, Protein, and WBC Levels
1978
Primary prophylaxis for variceal bleeding: Are we there yet?
2005
Transcription of the sex-determining region genes Sry and Zfy in the mouse preimplantation embryo.
1993
Cellular sources of glutathione S-transferase P in primary cultured rat hepatocytes: localization by in situ hybridization
1994
Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.
1994
Allopurinol-hypersensitivity vasculitis and liver damage.
1977
Direct Transhepatic Measurement of Portal Vein Pressure Using a Thin Needle
1977
Excretion of glutathione conjugates by primary cultured rat hepatocytes.
1987